The marketing platform developer was valued at $2bn in a series E round backed by DTCP and existing investor Capital One Ventures.

UPMC Enterprises has contributed to a series B round for Sempre Health, which is building a platform to make drugs more affordable for patients.

The solid-state battery maker will get a Nasdaq listing through the deal, which follows $161m in funding the company raised since being spun out of CU Boulder.

The events-focused social network secured its latest funding at a $1.2bn valuation, in a round led by SoftBank Vision Fund 2.

Alexandria Venture Investments returned to invest in a series C round that lifted the radiopharmaceutical developer's overall funding to $258m.

Susquehanna Growth Equity has returned to reinvest in the web design platform operator, which has amassed $100m in funding in total.

Kraft Group has once again participated in a funding round for the RNA drug developer, having backed its series A round three years ago.

Gene therapy startup VectorY has raised more than $37m in an Eli Lilly-backed seed round while AR helmet developer XYZ Reality pulled in over $28m.

The application development software provider has closed its initial public offering, with Zoom and Salesforce having bought $150m of shares.

The Aeon and American Express-backed online grocery retailer is set to list its shares on the Nasdaq Capital Market through a reverse takeover.